BABY 34.00 Natus Medical Inc $BABY Hit a 52 week h
Post# of 25
Posted On: 11/14/2014 10:35:46 AM
BABY 34.00 Natus Medical Inc $BABY Hit a 52 week high of 34.54 Closing the day 09:45 at 34.00 -0.31 -0.90% With a day low of 34.10 and a total volume of 14,921.
BABY Recent Posts: http://investorshangout.com/Natus-Medical-Inc-BABY-53443/
BABY Natus Medical Inc Recent Headline News
Exactech (EXAC) Down to Strong Sell On Dismal Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 12:30PM CST
Exactech Inc.'s (EXAC) lackluster third-quarter 2014 results (reported on Oct 21), with both earnings and revenues missing expectations, have set a negative earnings estimate revision trend for the company.
ICUI: 85.24 (+0.29), BABY: 34.09 (-0.22), EXAC: 22.61 (+0.14), IDXX: 151.67 (-0.83)
Shares of BABY Up 32.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Nov 13, 10:03AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 7 months, Natus Medical has returned 32.62% as of today's recent price of $34.60.
BABY: 34.09 (-0.22)
Asia-Pacific Markets for Patient Monitoring Devices and Equipment 2014
M2 - Thu Nov 13, 6:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/6jjwbm/asiapacific) has announced the addition of the "Asia-Pacific Markets for Patient Monitoring Devices and Equipment 2014" report to their offering. The market for patient monitoring includes multi-parameter vital sign monitors, wireless ambulatory telemetry monitors, electromyogram (EMG) devices and consumables, electroencephalogram (EEG) monitors, fetal and neonatal monitors and pulse oximetry monitors and sensors. Report Contents: - Identified Strategic Opportunities - Market Overview by Segment & Country - Trend Analysis by Segment & Country - Market Drivers & Limiters - Mergers & Acquisitions - Competitive Analysis Key Highlights: - Includes additional information on reimbursement changes - Brazil report includes a section in appendix on public vs. private market pricing - Descriptive and qualitative information for the market drivers and limiters for each segment - New large segment - Processed EEG Depth of Anesthesia Monitoring - Extensive Qualitative insights into emerging trends and consumer retail sub-markets Key Topics Covered: 1. Executive Summary 2. Research Methodology 3. Asia-Pacific Patient Monitoring Equipment Market Overview 4. Country Profiles 5. Multi-Parameter Vital Sign Monitoring Market 6. Wireless Ambulatory Telemetry Monitor Market 7. Electromyogram Monitoring And Diagnostic Market 8. Electroencephalogram Monitoring And Diagnostic Market 9. Fetal And Neonatal Monitoring Market 10. Pulse Oximeter Market 11. Abbreviations Companies Mentioned - ArjoHuntleigh - Beijing Choice - Bionet - Cardiac Science - CareFusion - Compumedics - Covidien - Draeger Medical - Edan - Fukuda Denshi - GE Healthcare - Grass Technologies - Masimo - Mediana - Mindray - Natus Medical - Nihon Kohden - Nonin - Omron Healthcare - Philips Healthcare - Smiths Medical - Spacelabs - Teijin Pharma - Welch Allyn For more information visit http://www.researchandmarkets.com/research/6j...siapacific
BABY: 34.09 (-0.22), CFN: 57.56 (unch)
Natus Medical Has Returned 29.9% Since SmarTrend Recommendation (BABY)
Comtex SmarTrend(R) - Thu Nov 06, 9:12AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 7 months, Natus Medical has returned 29.90% as of today's recent price of $33.89.
BABY: 34.09 (-0.22)
Sleep Apnea Diagnostic and Therapeutic Devices - 2014 Global Strategic Business Report
M2 - Thu Oct 30, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbnnd7/sleep_apnea) has announced the addition of the "Sleep Apnea Diagnostic and Therapeutic Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many key and niche players such as: - Cadwell Laboratories, Inc. - CareFusion Corporation - Cleveland Medical Devices, Inc. - Compumedics Ltd. - DeVilbiss Healthcare - Global Medical Holdings LLC - Fisher & Paykel Healthcare Limited - GE Healthcare - Itamar Medical Ltd. - Invacare Corporation - Natus Medical Inc. - Embla Systems, Inc. - Grass Technologies - Philips Healthcare - ResMed Inc. - Teleflex Medical - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Dynamics 3. Sleep Apnea - A Synopsis 4. Sleep Apnea Diagnostic And Therapeutic Devices 5. Research Findings In Recent Past 6. Product Launches/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Middle East And Africa IV. Competitive Landscape Total Companies Profiled: 71 (including Divisions/Subsidiaries - 76) - The United States (48) - Canada (4) - Japan (1) - Europe (12) - - Germany (3) - - The United Kingdom (2) - - Italy (2) - - Spain (2) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (
- Middle East (3) For more information visit http://www.researchandmarkets.com/research/qb...leep_apnea
BABY: 34.09 (-0.22), IVC: 16.05 (+0.06), RMD: 52.03 (+0.04)
Shares of BABY Up 28.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 29, 4:49PM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 28.94% as of today's recent price of $33.64.
BABY: 34.09 (-0.22)
Edwards Lifesciences (EW) Worth Watching: Stock Up 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:25AM CDT
Edwards Lifesciences (EW) was a big mover last session, with shares rising 11% on the day.
BABY: 34.09 (-0.22), PACB: 6.70 (-0.23), EW: 124.15 (-0.40), ANGO: 16.76 (-0.10)
Is Natus Medical (BABY) a Great Growth Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:53AM CDT
If you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Natus Medical.
BABY: 34.09 (-0.22)
3 Momentum Stocks to Watch in Biotechnology for Continued Upside
at The Street - Thu Oct 23, 2:39PM CDT
Wednesday was a strong session for a number of stocks, and here are three, in particular, to watch for more upside.
BABY: 34.09 (-0.22), RGLS: 17.81 (+0.07), AGIO: 84.78 (-1.71)
Natus Medical Rises 1.71% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Oct 22, 5:38PM CDT
Natus Medical (NASDAQ:BABY) traded in a range yesterday that spanned from a low of $31.06 to a high of $33.20. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $32.44 on volume of 863,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BABY: 34.09 (-0.22)
Natus Medical's (BABY) CEO Jim Hawkins on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 22, 1:57PM CDT
BABY: 34.09 (-0.22)
Natus Medical Inc. Hears Higher Margins Calling
Brian Orelli, The Motley Fool - Motley Fool - Wed Oct 22, 1:53PM CDT
Organic revenue growth of 5% is nothing to get too excited about, but increasing margins made for a nice bottom-line improvement at Natus Medical . Non-GAAP net income increased 16.5% year over year in the third quarter to $10.6 million. Gross...
BABY: 34.09 (-0.22)
Natus Medical Shares Up 19.4% Since SmarTrend's Buy Recommendation (BABY)
Comtex SmarTrend(R) - Wed Oct 22, 11:05AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 19.39% as of today's recent price of $31.15.
BABY: 34.09 (-0.22)
Natus Medical Incorporated (BABY) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 22, 9:55AM CDT
BABY: 34.09 (-0.22)
Natus Medical raises guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 8:29AM CDT
BABY: 34.09 (-0.22)
Natus Medical tops Street 3Q forecasts
Automated Insights - Wed Oct 22, 6:57AM CDT
SAN CARLOS, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported earnings of $7.8 million in its third quarter.
BABY: 34.09 (-0.22)
Natus Medical beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 6:15AM CDT
BABY: 34.09 (-0.22)
Natus Medical Announces Record Third Quarter and Year-to-Date 2014 Financial Results
GlobeNewswire - Wed Oct 22, 6:04AM CDT
-- Reports organic revenue growth of 5% for the third quarter
BABY: 34.09 (-0.22)
Don't Miss Today's Strong And Under The Radar Stock: Natus Medical (BABY)
at The Street - Tue Oct 21, 8:51AM CDT
Trade-Ideas LLC identified Natus Medical (BABY) as a strong and under the radar candidate
BABY: 34.09 (-0.22)
Natus Medical Announces First of Kind Vista Ultrasound System
GlobeNewswire - Thu Oct 16, 6:00AM CDT
Natus Medical Incorporated (Nasdaq:BABY) today announced the launch of the Vista Ultrasound System. The Vista Ultrasound System is the first product in the market to enable the use of Ultrasound with an EMG workstation. The Vista Ultrasound System adds ultrasound capability to Natus' market leading EDX and UltraPro S100 EMG workstations. The new Vista Ultrasound System will be available worldwide.
BABY: 34.09 (-0.22)
BABY Recent Posts: http://investorshangout.com/Natus-Medical-Inc-BABY-53443/
BABY Natus Medical Inc Recent Headline News
Exactech (EXAC) Down to Strong Sell On Dismal Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 12:30PM CST
Exactech Inc.'s (EXAC) lackluster third-quarter 2014 results (reported on Oct 21), with both earnings and revenues missing expectations, have set a negative earnings estimate revision trend for the company.
ICUI: 85.24 (+0.29), BABY: 34.09 (-0.22), EXAC: 22.61 (+0.14), IDXX: 151.67 (-0.83)
Shares of BABY Up 32.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Nov 13, 10:03AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 7 months, Natus Medical has returned 32.62% as of today's recent price of $34.60.
BABY: 34.09 (-0.22)
Asia-Pacific Markets for Patient Monitoring Devices and Equipment 2014
M2 - Thu Nov 13, 6:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/6jjwbm/asiapacific) has announced the addition of the "Asia-Pacific Markets for Patient Monitoring Devices and Equipment 2014" report to their offering. The market for patient monitoring includes multi-parameter vital sign monitors, wireless ambulatory telemetry monitors, electromyogram (EMG) devices and consumables, electroencephalogram (EEG) monitors, fetal and neonatal monitors and pulse oximetry monitors and sensors. Report Contents: - Identified Strategic Opportunities - Market Overview by Segment & Country - Trend Analysis by Segment & Country - Market Drivers & Limiters - Mergers & Acquisitions - Competitive Analysis Key Highlights: - Includes additional information on reimbursement changes - Brazil report includes a section in appendix on public vs. private market pricing - Descriptive and qualitative information for the market drivers and limiters for each segment - New large segment - Processed EEG Depth of Anesthesia Monitoring - Extensive Qualitative insights into emerging trends and consumer retail sub-markets Key Topics Covered: 1. Executive Summary 2. Research Methodology 3. Asia-Pacific Patient Monitoring Equipment Market Overview 4. Country Profiles 5. Multi-Parameter Vital Sign Monitoring Market 6. Wireless Ambulatory Telemetry Monitor Market 7. Electromyogram Monitoring And Diagnostic Market 8. Electroencephalogram Monitoring And Diagnostic Market 9. Fetal And Neonatal Monitoring Market 10. Pulse Oximeter Market 11. Abbreviations Companies Mentioned - ArjoHuntleigh - Beijing Choice - Bionet - Cardiac Science - CareFusion - Compumedics - Covidien - Draeger Medical - Edan - Fukuda Denshi - GE Healthcare - Grass Technologies - Masimo - Mediana - Mindray - Natus Medical - Nihon Kohden - Nonin - Omron Healthcare - Philips Healthcare - Smiths Medical - Spacelabs - Teijin Pharma - Welch Allyn For more information visit http://www.researchandmarkets.com/research/6j...siapacific
BABY: 34.09 (-0.22), CFN: 57.56 (unch)
Natus Medical Has Returned 29.9% Since SmarTrend Recommendation (BABY)
Comtex SmarTrend(R) - Thu Nov 06, 9:12AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 7 months, Natus Medical has returned 29.90% as of today's recent price of $33.89.
BABY: 34.09 (-0.22)
Sleep Apnea Diagnostic and Therapeutic Devices - 2014 Global Strategic Business Report
M2 - Thu Oct 30, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbnnd7/sleep_apnea) has announced the addition of the "Sleep Apnea Diagnostic and Therapeutic Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many key and niche players such as: - Cadwell Laboratories, Inc. - CareFusion Corporation - Cleveland Medical Devices, Inc. - Compumedics Ltd. - DeVilbiss Healthcare - Global Medical Holdings LLC - Fisher & Paykel Healthcare Limited - GE Healthcare - Itamar Medical Ltd. - Invacare Corporation - Natus Medical Inc. - Embla Systems, Inc. - Grass Technologies - Philips Healthcare - ResMed Inc. - Teleflex Medical - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Dynamics 3. Sleep Apnea - A Synopsis 4. Sleep Apnea Diagnostic And Therapeutic Devices 5. Research Findings In Recent Past 6. Product Launches/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Middle East And Africa IV. Competitive Landscape Total Companies Profiled: 71 (including Divisions/Subsidiaries - 76) - The United States (48) - Canada (4) - Japan (1) - Europe (12) - - Germany (3) - - The United Kingdom (2) - - Italy (2) - - Spain (2) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (
- Middle East (3) For more information visit http://www.researchandmarkets.com/research/qb...leep_apnea BABY: 34.09 (-0.22), IVC: 16.05 (+0.06), RMD: 52.03 (+0.04)
Shares of BABY Up 28.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 29, 4:49PM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 28.94% as of today's recent price of $33.64.
BABY: 34.09 (-0.22)
Edwards Lifesciences (EW) Worth Watching: Stock Up 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:25AM CDT
Edwards Lifesciences (EW) was a big mover last session, with shares rising 11% on the day.
BABY: 34.09 (-0.22), PACB: 6.70 (-0.23), EW: 124.15 (-0.40), ANGO: 16.76 (-0.10)
Is Natus Medical (BABY) a Great Growth Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:53AM CDT
If you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Natus Medical.
BABY: 34.09 (-0.22)
3 Momentum Stocks to Watch in Biotechnology for Continued Upside
at The Street - Thu Oct 23, 2:39PM CDT
Wednesday was a strong session for a number of stocks, and here are three, in particular, to watch for more upside.
BABY: 34.09 (-0.22), RGLS: 17.81 (+0.07), AGIO: 84.78 (-1.71)
Natus Medical Rises 1.71% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Oct 22, 5:38PM CDT
Natus Medical (NASDAQ:BABY) traded in a range yesterday that spanned from a low of $31.06 to a high of $33.20. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $32.44 on volume of 863,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BABY: 34.09 (-0.22)
Natus Medical's (BABY) CEO Jim Hawkins on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 22, 1:57PM CDT
BABY: 34.09 (-0.22)
Natus Medical Inc. Hears Higher Margins Calling
Brian Orelli, The Motley Fool - Motley Fool - Wed Oct 22, 1:53PM CDT
Organic revenue growth of 5% is nothing to get too excited about, but increasing margins made for a nice bottom-line improvement at Natus Medical . Non-GAAP net income increased 16.5% year over year in the third quarter to $10.6 million. Gross...
BABY: 34.09 (-0.22)
Natus Medical Shares Up 19.4% Since SmarTrend's Buy Recommendation (BABY)
Comtex SmarTrend(R) - Wed Oct 22, 11:05AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 19.39% as of today's recent price of $31.15.
BABY: 34.09 (-0.22)
Natus Medical Incorporated (BABY) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 22, 9:55AM CDT
BABY: 34.09 (-0.22)
Natus Medical raises guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 8:29AM CDT
BABY: 34.09 (-0.22)
Natus Medical tops Street 3Q forecasts
Automated Insights - Wed Oct 22, 6:57AM CDT
SAN CARLOS, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported earnings of $7.8 million in its third quarter.
BABY: 34.09 (-0.22)
Natus Medical beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 6:15AM CDT
BABY: 34.09 (-0.22)
Natus Medical Announces Record Third Quarter and Year-to-Date 2014 Financial Results
GlobeNewswire - Wed Oct 22, 6:04AM CDT
-- Reports organic revenue growth of 5% for the third quarter
BABY: 34.09 (-0.22)
Don't Miss Today's Strong And Under The Radar Stock: Natus Medical (BABY)
at The Street - Tue Oct 21, 8:51AM CDT
Trade-Ideas LLC identified Natus Medical (BABY) as a strong and under the radar candidate
BABY: 34.09 (-0.22)
Natus Medical Announces First of Kind Vista Ultrasound System
GlobeNewswire - Thu Oct 16, 6:00AM CDT
Natus Medical Incorporated (Nasdaq:BABY) today announced the launch of the Vista Ultrasound System. The Vista Ultrasound System is the first product in the market to enable the use of Ultrasound with an EMG workstation. The Vista Ultrasound System adds ultrasound capability to Natus' market leading EDX and UltraPro S100 EMG workstations. The new Vista Ultrasound System will be available worldwide.
BABY: 34.09 (-0.22)
(0)
(0)